跳至主要内容
临床试验/ISRCTN31345163
ISRCTN31345163已完成不适用

GENetic and clinical Predictors Of treatment response in Depressio

Medical Research Council (UK)0 个研究点目标入组 887 人开始时间: 2003年9月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
887

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 18-74 years with the more severe depressions in whom the GP and patient have already agreed that antidepressants should be prescribed. We will therefore only include those with a Clinical Interview Schedule - Revised (CIS-R) score of =20, a Beck Depression Inventory (BDI) score of =15 and a diagnosis of International Statistical Classification of Diseases and Related Health Problems, tenth revision (ICD-10) depressive episode F32 and F33 (from CIS-R).

排除标准

  • Pregnant and breast feeding women, patients with psychotic illness, alchohol or substance abuse problems, patients with medical contraindications to Citalopram or Reboxetine. (June 2006: Exclusion criteria were provided as follows: Potential subjects who have taken antidepressant medication within 2 weeks, who cannot complete self-administered scales, who have a psychosis or major substance or alcohol abuse. The GP will exclude anyone who has medical contraindications or in whom participation in the trial is not appropriate.)

研究者

发起方
Medical Research Council (UK)

相似试验